Article
Kalshi and Polymarket bets on clinical trials criticized as 'ghastly'
Bearish
-55.0
−100 Bearish
0
+100 Bullish
Researchers warn betting on clinical trials could incentivize insider trading and interfere with drug development. But Kalshi and Polymarket say they provide valuable information to patients.
Actions
Pulse AI
Pulse analysis not available yet. Click "Get Pulse" above.
Generated by Pulse AI, Glideslope's proprietary engine for interpreting market sentiment and economic signals. For informational purposes only — not financial advice.
Article Info
Sentiment Signal
Bearish
-55.0
−100Neutral+100
More Like This